PAPER Bourdenx M, Dehay B, Bezard E
SEARCH RESULTS
331209 RESULTS
PAPER Buddhala C, Campbell MC, Perlmutter JS, Kotzbauer PT
Correlation between decreased CSF α-synuclein and Aβ₁₋₄₂ in Parkinson disease.
Neurobiol Aging. 2015 Jan;36(1):476-84. Epub 2014 Aug 4 PubMed: 25212463PAPER Fang YS, Tsai KJ, Chang YJ, Kao P, Woods R, Kuo PH, Wu CC, Liao JY, Chou SC, Lin V, Jin LW, Yuan HS, Cheng IH, Tu PH, Chen YR
Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients.
Nat Commun. 2014 Sep 12;5:4824. PubMed: 25215604PAPER Cai M, Lee KW, Choi SM, Yang EJ
TDP-43 modification in the hSOD1(G93A) amyotrophic lateral sclerosis mouse model.
Neurol Res. 2015 Mar;37(3):253-62. Epub 2014 Sep 12 PubMed: 25213598PAPER Philips T, Rothstein JD, Pouladi MA
Preclinical models: needed in translation? A Pro/Con debate.
Mov Disord. 2014 Sep 15;29(11):1391-6. PubMed: 25216370PAPER Wu Z, Guo Z, Gearing M, Chen G
Corrigendum: Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzheimer's disease model.
Nat Commun. 2014 Sep 12;5:4810. PubMed: 25215447PAPER Marlatt MW, Bauer J, Aronica E, van Haastert ES, Hoozemans JJ, Joels M, Lucassen PJ
Proliferation in the Alzheimer hippocampus is due to microglia, not astroglia, and occurs at sites of amyloid deposition.
Neural Plast. 2014;2014:693851. Epub 2014 Aug 19 PubMed: 25215243PAPER Lin AL, Rothman DL
What have novel imaging techniques revealed about metabolism in the aging brain?
Future Neurol. 2014 May 1;9(3):341-354. PubMed: 25214817PAPER Martande SS, Pradeep AR, Singh SP, Kumari M, Suke DK, Raju AP, Naik SB, Singh P, Guruprasad CN, Chatterji A
Periodontal health condition in patients with Alzheimer's disease.
Am J Alzheimers Dis Other Demen. 2014 Sep;29(6):498-502. PubMed: 25214647PAPER Li W, Yu J, Liu Y, Huang X, Abumaria N, Zhu Y, Huang X, Xiong W, Ren C, Liu XG, Chui D, Liu G
Elevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in Alzheimer's disease mouse model.
Mol Brain. 2014 Sep 13;7:65. PubMed: 25213836PAPER Riverol M, Becker JT, López OL, Raji CA, Thompson PM, Carmichael OT, Gach HM, Longstreth WT Jr, Fried L, Tracy RP, Kuller LH
Relationship between Systemic and Cerebral Vascular Disease and Brain Structure Integrity in Normal Elderly Individuals.
J Alzheimers Dis. 2015;44(1):319-28. PubMed: 25213770PAPER van Buchem MA, Biessels GJ, Brunner la Rocca HP, de Craen AJ, van der Flier WM, Ikram MA, Kappelle LJ, Koudstaal PJ, Mooijaart SP, Niessen W, van Oostenbrugge R, de Roos A, van Rossum AC, Daemen MJ
The heart-brain connection: a multidisciplinary approach targeting a missing link in the pathophysiology of vascular cognitive impairment.
J Alzheimers Dis. 2014;42 Suppl 4:S443-51. PubMed: 25213769PAPER Wattmo C, Londos E, Minthon L
Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease.
BMC Neurol. 2014 Sep 10;14:173. PubMed: 25213579PAPER Yan S, Li Z, Li H, Arancio O, Zhang W
Notoginsenoside R1 increases neuronal excitability and ameliorates synaptic and memory dysfunction following amyloid elevation.
Sci Rep. 2014 Sep 12;4:6352. PubMed: 25213453PAPER Jain S, Rathod V, Prajapati R, Nandekar PP, Sangamwar AT
Pregnane X Receptor and P-glycoprotein: a connexion for Alzheimer's disease management.
Mol Divers. 2014 Nov;18(4):895-909. Epub 2014 Sep 12 PubMed: 25213397Current Filters
No filters selected